Loading...

Atlas Bangladesh, Central Pharmaceuticals recommend dividend

FE Online Report | Published: November 04, 2019 11:57:26 | Updated: November 05, 2019 11:47:34


The board of directors of two more listed companies – Atlas Bangladesh and Central Pharmaceuticals have recommended 6.0 per cent dividend for the year ended on June 30, 2019, according to separate official disclosures on Monday.

Atlas Bangladesh: The board of directors of Atlas Bangladesh has recommended 5.0 per cent cash dividend for the year ended on June 30, 2019.

The final approval of dividend will come during the Annual General Meeting (AGM) scheduled to be held on December 21, 2019.

The record date is November 24, 2019.

The company has also reported EPS of Tk (0.99), NAV per share of Tk 133.00 and NOCFPS of Tk (1.70) for the year ended on June 30, 2019 as against Tk (1.11), Tk 148.00 and Tk. 1.46 respectively for the same period of the previous year.

Central Pharma: The board of directors of Central Pharmaceuticals has recommended 1.0 per cent cash dividend for the year ended on June 30, 2019.

The final approval of dividend will come during the Annual General Meeting (AGM) scheduled to be held on December 30, 2019 in Dhaka.

The record date is November 25, 2019.

The Company has also reported EPS of Tk 0.48, NAV per share of Tk 14.87 and NOCFPS of Tk 0.09 for the year ended on June 30, 2019 as against Tk 0.51 (adjusted), Tk 15.04 (adjusted) and Tk 0.24 (adjusted) respectively for the same period of the previous year.

babulfexpress@gmail.com

Share if you like